1 ๐๏ธ๐ ๐๐ก๐ซ๐จ๐ฐ๐๐๐๐ค ๐ญ๐จ ๐จ๐ง๐ ๐จ๐ ๐ฅ๐๐ฌ๐ญ ๐ฒ๐๐๐ซ'๐ฌ ๐ก๐จ๐ญ๐ญ๐๐ฌ๐ญ ๐ญ๐ซ๐ข๐๐ฅ ๐๐ข๐ฌ๐๐ฎ๐ฌ๐ฌ๐ข๐จ๐ง๐ฌ: SURPASS-CVOT (tirzepatide vs dulaglutide on MACE in #T2D + ASCVD). Missed it? Catch up now ๐ Back at #EASD2026 too: ๐ Wed, 30 Sep 2026 | ๐ 08:30 - 09:30 |๐ Dublin Hall ๐ง Listen here: diabetes-insights.podigee.io/47-surpass-c... 0 comments ยท 1d ago ยท by European Association for the Study of Diabetes #easd2026#t2d
